Clonal analysis of gene loss of function and tissue-specific gene deletion in zebrafish via CRISPR/Cas9 technology

被引:1
|
作者
De Santis, F. [1 ]
Di Donato, V. [1 ]
Del Bene, F. [1 ]
机构
[1] PSL Res Univ, Paris, France
关键词
SITE-SPECIFIC RECOMBINATION; CONDITIONAL MUTAGENESIS; DROSOPHILA; MICE; SYSTEM; GENOME; EXPRESSION; PROGENITORS; MOSAICS; CELLS;
D O I
10.1016/bs.mcb.2016.03.006
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
In the last few years the development of CRISPR/Cas 9-mediated genome editing techniques has allowed the efficient generation of loss-of-function alleles in several model organisms including zebrafish. However, these methods are mainly devoted to target-specific genomic loci leading to the creation of constitutive knock-out models. On the contrary, the analysis of gene function via tissue-or cell-specific mutagenesis remains challenging in zebrafish. To circumvent this limitation, we present here a simple and versatile protocol to achieve tissue-specific gene disruption based on the Cas9 expression under the control of the Gal4/upstream activating sequence binary system. In our method, we couple Cas9 with green fluorescent protein or Cre reporter gene expression. This strategy allows us to induce somatic mutations in genetically labeled cell clones or single cells, and to follow them in vivo via reporter gene expression. Importantly, because none of the tools that we present here are restricted to zebrafish, similar approaches are readily applicable in virtually any organism where transgenesis and DNA injection are feasible.
引用
收藏
页码:171 / 188
页数:18
相关论文
共 50 条
  • [31] Markerless chromosomal gene deletion in Clostridium beijerinckii using CRISPR/Cas9 system
    Wang, Yi
    Zhang, Zhong-Tian
    Seo, Seung-Oh
    Choi, Kijoong
    Lu, Ting
    Jin, Yong-Su
    Blaschek, Hans P.
    JOURNAL OF BIOTECHNOLOGY, 2015, 200 : 1 - 5
  • [32] CRISPR/Cas9 Mediated Deletion of the Angiotensinogen Gene Reduces Hypertension A Potential for Cure?
    Sun, Hualing
    Hodgkinson, Conrad P.
    Pratt, Richard E.
    Dzau, Victor J.
    HYPERTENSION, 2021, 77 (06) : 1990 - 2000
  • [33] Generation of Gene Exon Knockout Mice Using CRISPR/Cas9 Technology
    Liu, Y.
    Zhang, X. P.
    Wang, L. Y.
    Du, J.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2016, 64 : S378 - S378
  • [34] Nobel Prize in Chemistry 2020 for gene editing with CRISPR/Cas9 technology
    Luthy, Isabel A.
    Lamb, Caroline A.
    MEDICINA-BUENOS AIRES, 2020, 80 (06) : 738 - 740
  • [35] CRISPR/Cas9 mutation-specific gene editing for ADA SCID
    Calero-Garcia, M.
    Carmo, M.
    Thrasher, A. J.
    Gaspar, H. B.
    HUMAN GENE THERAPY, 2015, 26 (10) : A45 - A45
  • [36] Generation of pRSAD2 gene knock-in pig via CRISPR/Cas9 technology
    Xie, Zicong
    Jiao, Huping
    Xiao, Haonan
    Jiang, Yuan
    Liu, Zhenying
    Qi, Chunyun
    Zhao, Dehua
    Jiao, Shuyu
    Yu, Tingting
    Tang, Xiaochun
    Pang, Daxin
    Ouyang, Hongsheng
    ANTIVIRAL RESEARCH, 2020, 174
  • [37] NHEJ and CRISPR–Cas9 improve gene therapy
    Eytan Zlotorynski
    Nature Reviews Molecular Cell Biology, 2017, 18 (1) : 4 - 4
  • [38] CRISPR/Cas9 Essential Gene Editing in Drosophila
    Osadchiy, I. S.
    Kamalyan, S. O.
    Tumashova, K. Y.
    Georgiev, P. G.
    Maksimenko, O. G.
    ACTA NATURAE, 2023, 15 (02): : 70 - 74
  • [39] Optical Control of CRISPR/Cas9 Gene Editing
    Hemphill, James
    Borchardt, Erin K.
    Brown, Kalyn
    Asokan, Aravind
    Deiters, Alexander
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2015, 137 (17) : 5642 - 5645
  • [40] Spatiotemporal control of CRISPR/Cas9 gene editing
    Chenya Zhuo
    Jiabin Zhang
    Jung-Hwan Lee
    Ju Jiao
    Du Cheng
    Li Liu
    Hae-Won Kim
    Yu Tao
    Mingqiang Li
    Signal Transduction and Targeted Therapy, 6